They found that younger age, estrogen receptor (ER)-negative status, HER2-positive status, higher tumor stage, higher histologic grade (HG), large tumor size, and high Ki67 labeling index were independent risk factors for BCBM. This evidence concerns the gene ERBB2 and neoplasm.